Q3 2015
Released Nov 4, 2015, after the close
10-Q filed Nov 4, 2015, 35 days after period end · 0001237831-15-000060
Q3 2015 · 10-Q
Revenue$136.99M$136.99M +16.3% vs Q3 2014+2.6% vs Q2 2015
Net Income$26.48M$26.48M +14.8% vs Q3 2014+10.1% vs Q2 2015
EPS Diluted$0.28$0.28 +16.7% vs Q3 2014+12.0% vs Q2 2015
Gross Profit$104,065,000+15.5%
Operating Income$40,675,000+16.5%
Operating Cash Flowderived$30,046,000−15.7%
Free Cash Flowderived$18,566,000−42.4%
Margins · derived
Gross margin76.0%−0.5 pt vs Q3 2014
Operating margin29.7%+0.0 pt vs Q3 2014
Net margin19.3%−0.2 pt vs Q3 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $136.99M | $117.79M | $107.19M | $94.76M |
| Net Income | $26.48M | $23.06M | $20.31M | $16.49M |
| EPS Diluted | $0.28 | $0.24 | $0.22 | $0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR